Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Principal Fin. & Acctng Ofc.

President and CEO

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; and HPN217 that is in Phase I clinical trials for the treatment of multiple myeloma. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. It has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. The company was incorporated in 2015 and is headquartered in South San Francisco, California.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that ha...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	Chief Medical Officer
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	Principal Fin. & Acctng Ofc.
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	President and CEO
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	bought	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-11	Premium	back to issuer	Premium	Premium	Premium	-
2024-03-08	Premium	acquired	Premium	Premium	Premium	-
2024-03-08	Premium	acquired	Premium	Premium	Premium	-
2024-03-08	Premium	acquired	Premium	Premium	Premium	-
2024-01-07	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-01-07	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-07	Premium	acquired	Premium	Premium	Premium	Principal Fin. & Acctng Ofc.
2024-01-01	Premium	acquired	Premium	Premium	Premium	-
2024-01-01	Premium	acquired	Premium	Premium	Premium	-

HARP - Harpoon Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for HARP